Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging



Status:Recruiting
Healthy:No
Age Range:55 - Any
Updated:6/9/2018
Start Date:May 8, 2018
End Date:May 31, 2022
Contact:Lindsay Dillon
Email:ldillon@ucsd.edu
Phone:8585349329

Use our guide to learn which trials are right for you!

Sedentary Behavior Interrupted: A Randomized Crossover Trial of Acute Effects on Biomarkers of Healthy Aging in the Laboratory (Project 1)

This protocol "Sedentary Behavior Interrupted: A randomized crossover trial of acute effects
on biomarkers of healthy aging in the laboratory (Project 1)" is part of a National
Institutes of Aging Program Grant called "Sedentary Time & Aging Mortality and Physical
Function (STAR). The overall purpose of the STAR program to is to better understand how to
interrupt sitting time and the consequences for healthy aging in postmenopausal women. This
protocol (also referred to Project 1 of the STAR program) is a 3-condition randomized
crossover clinical trial of up to 86 postmenopausal women to test whether different
interruptions to prolonged sitting improve metabolism.

The specific aims of this protocol include:

Aim 1. To investigate the acute effect of sitting interruption modalities on postprandial
glucose and insulin concentrations, compared to prolonged sitting.

Aim 2. To investigate the acute effect of sitting interruption modalities on the physiologic
parameters of endothelial function, compared to prolong sitting.

Aim 3. To explore the moderating effect of age.

Inclusion Criteria:

- female

- 55 years of age and above

- any ethnicity or race

- screened to sit for 8 or more hours per day, perform less than 60 sit-to-stand
transitions per day & engage in less than 20 minutes of moderate-to-vigorous physical
activity (MVPA) per day

- BMI 25 - 45 kg/m2

- ambulatory

- medically stable without any health conditions that would inhibit standing or PA;

- able to give informed consent & comply with study protocols;

- able to read, communicate, and write fluently in English;

- able to travel to study visits;

- no menstruation for at least one year;

- not participating or not planning to participate in a physical activity or weight loss
program or research study.

Exclusion Criteria:

- Mental state that would preclude complete understanding of the protocol or compliance;

- type 1 diabetes;

- type 2 diabetes using insulin or with poor glycemic control (greater than 10% for all
participants);

- poorly controlled hypertension (Systolic Blood Pressure ≥165 or Diastolic Blood
Pressure ≥100);

- chronic illness that may be associated with weight change (HIV/AIDS, active cancer, or
uncontrolled thyroid disease),

- anemia (hemoglobin ≤11g/dL);

- personal or first-degree relative history of venous thrombosis;

- weight instability in past 3 months (no more than 5% up or down);

- regular use of vasodilator medication and high risk of stroke and/or heart attack
(i.e., history of multiple hospitalizations (>2X) in the last 6 months), congestive
heart failure, atrial fibrillation, and/or stroke;

- regular use of immunosuppressant or corticosteroid medication;

- blood donation less than 56 days prior to screening visit,

- smoking cigarettes or smoking or ingesting anything, and other use of tobacco products
including e-cigarettes.

- diagnosis of orthostatic hypotension
We found this trial at
1
site
La Jolla, California 92093
Phone: 858-534-9333
?
mi
from
La Jolla, CA
Click here to add this to my saved trials